A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic - PubMed (original) (raw)

A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic

H Maeda et al. Int J Pept Protein Res. 1979 Aug.

Abstract

A lipophilic derivative of neocarzinostatin (NCS), an antitumor antibiotic, was prepared by reaction with a synthetic water-soluble polymer, [(styrene)1 approximately 3-(maleic acid 4 approximately 7/anhydride 1)]. The reaction was carried out at pH 8.6 for 3 h and aimed at modifying the two nonessential amino groups (alpha-amino of Ala-1, epsilon-amino of Lys-20). The NCS-polystyrene (SMANCS) was purified on a column of Sephadex G-100 in 0.05 M ammonium bicarbonate and the main product was obtained as a single peak. The elemental analysis showed an increased C and a decreased N content. U.v. and i.r. absorption spectra for SMANCS showed the presence of styrene. SDS-acrylamide gel electrophoresis at pH 8.5 and the decreased N content suggested a molecular weight of about 25 000, indicating the numbers of polymers conjugated to be about six units, two of which were found attached to the two amino groups. SMANCS was soluble in organic solvents, in contrast to NCS, and in water. SMANCS exhibited increased chemical and biological stability and appeared to possess similar in vitro biological activity.

PubMed Disclaimer

Similar articles

• [SMANCS/lipiodol].
  Maeda H. Maeda H. Gan To Kagaku Ryoho. 1994 May;21(6):907-13. Gan To Kagaku Ryoho. 1994. PMID: 8185354 Review. Japanese.

Cited by

• Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy.
  Junyaprasert VB, Thummarati P. Junyaprasert VB, et al. Pharmaceutics. 2023 Aug 27;15(9):2216. doi: 10.3390/pharmaceutics15092216. Pharmaceutics. 2023. PMID: 37765185 Free PMC article. Review.
• Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine.
  Galassi L, Rossi M, Lodeserto P, Lenzi M, Borsetti F, Voltattorni M, Farruggia G, Blasi P, Orienti I. Galassi L, et al. Pharmaceutics. 2023 Feb 15;15(2):648. doi: 10.3390/pharmaceutics15020648. Pharmaceutics. 2023. PMID: 36839972 Free PMC article.
• Bioactive Glasses as Carriers of Cancer-Targeted Drugs: Challenges and Opportunities in Bone Cancer Treatment.
  Borges R, Pelosine AM, de Souza ACS, Machado J Jr, Justo GZ, Gamarra LF, Marchi J. Borges R, et al. Materials (Basel). 2022 Dec 19;15(24):9082. doi: 10.3390/ma15249082. Materials (Basel). 2022. PMID: 36556893 Free PMC article. Review.
• Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines.
  Lodeserto P, Rossi M, Blasi P, Farruggia G, Orienti I. Lodeserto P, et al. Pharmaceutics. 2022 Jun 7;14(6):1215. doi: 10.3390/pharmaceutics14061215. Pharmaceutics. 2022. PMID: 35745787 Free PMC article.
• Controlled release nanoplatforms for three commonly used chemotherapeutics.
  Costoya J, Surnar B, Kalathil AA, Kolishetti N, Dhar S. Costoya J, et al. Mol Aspects Med. 2022 Feb;83:101043. doi: 10.1016/j.mam.2021.101043. Epub 2021 Dec 14. Mol Aspects Med. 2022. PMID: 34920863 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations